Exact Mass: 726.377839
Exact Mass Matches: 726.377839
Found 138 metabolites which its exact mass value is equals to given mass value 726.377839
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Adiantifoline
Torvoside D
Torvoside D is found in fruits. Torvoside D is a constituent of Solanum torvum (pea eggplant) Constituent of Solanum torvum (pea eggplant). Torvoside D is found in fruits.
furost-5(6)-en-3beta,22alpha-diol 1beta-O-beta-D-xylopyranosyl 26-O-alpha-L-rhamnopyranoside|tropeoside B1
25(S)-5beta-spirostan-1beta,3beta,17alpha-triol 1-O-alpha-L-rhamnopyranosyl-(1->2)-beta-D-xylopyranoside|reineckiagenoside B
16beta-[(alpha-L-arabinopyranosyl)oxy)]-3beta-[(beta-D-glucopyranosyl)oxy]-17alpha-hydroxycholest-5-en-22-one|16beta-[(alpha-L-arabinopyranosyl)oxy]-3beta-[(beta-D-glucopyranosyl)oxy]-17alpha-hydroxycholest-5-en-22-one
neochlorogenin 6-O-[beta-D-xylopyranosyl-(1?3)-beta-D-glucopyranoside]|torvoside Q
7,23-di-O-beta-glucopyranoside of 3,7,23-trihydroxycucurbita-5,24-dien-19-al
(25R)-3beta-hydroxy-5alpha-spirostan-6alpha-yl O-beta-D-xylopyranosyl-(1->2)-beta-D-glucopyranoside
4-O-[beta-D-galactopyranosyl-(1->2)-beta-D-xylopyranosyl]-cholest-5,24-diene-2alpha,3beta,7beta-triol|wondosterol C
4-O-[beta-D-galactopyranosyl-(1->2)-beta-D-xylopyranosyl]-cholest-5,22-diene-2alpha,3beta,7beta-triol|wondosterol B
14beta,16beta-dihydroxy-3beta-[(beta-D-glucopyranosyl-(1->4)-O-beta-D-glucopyranosyl)oxy]-5beta-bufa-20,22-dienolide|tigencaoside B
Torvoside D
Microdiscusoside A
tris(2,2,6,6-tetramethyl-3,5-heptanedionato)ytterbium
bis(2,2,6,6-tetramethyl-3,5-heptanedionato)barium tetraglyme adduct
C32H60BaO9 (726.3289470000001)
2-Propenyl 6-deoxy-4-O-[2,3,4,6-tetrakis-O-(phenylmethyl)-alpha-D-glucopyranosyl]-alpha-L-mannopyranoside
Volasertib trihydrochloride
C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor
Methoctramine
D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D010276 - Parasympatholytics
n-[2(s)-Cyclopentyl-1(r)-hydroxy-3(r)methyl]-5-[(2(s)-tertiary-butylamino-carbonyl)-4-(n1-(2)-(n-methylpiperazinyl)-3-chloro-pyrazinyl-5-carbonyl)-piperazino]-4(s)-hydroxy-2(r)-phenylmethyl-pentanamide
C37H55ClN8O5 (726.3983729999999)
16beta-[(alpha-L-arabinopyranosyl)oxy]-3beta-[(beta-D-glucopyranosyl)oxy]-17alpha-hydroxycholest-5-en-22-one
A steroid saponin that is (3beta,16beta,20R)-3,16,17-trihydroxycholest-5-en-22-one attached to a alpha-L-arabinopyranosyl residue at position 16 and a beta-D-glucopyranosyl residue at position 3 via a glycosidic linkage. Isolated from Ornithogalum thyrsoides and Galtonia candicans, it exhibits cytotoxic activity.
(3E)-5-(hydroxy{3-[(2S,5S)-5-(3-{hydroxy[(2E)-5-hydroxy-3-methylpent-2-enoyl]amino}propyl)-3,6-dioxopiperazin-2-yl]propyl}amino)-3-methyl-5-oxopent-3-en-1-yl N(5)-hydroxy-N(5)-[(2E)-5-hydroxy-3-methylpent-2-enoyl]-L-ornithinate
[(2S,3S,6S)-6-[3-[(6E,9E)-dodeca-6,9-dienoyl]oxy-2-[(7E,9E,11E,13E)-hexadeca-7,9,11,13-tetraenoyl]oxypropoxy]-3,4,5-trihydroxyoxan-2-yl]methanesulfonic acid
[2-[(5E,7E,9E,11E,13E)-hexadeca-5,7,9,11,13-pentaenoyl]oxy-3-phosphonooxypropyl] (8E,11E,14E,17E,20E)-tricosa-8,11,14,17,20-pentaenoate
[2-[(7E,9E,11E,13E)-hexadeca-7,9,11,13-tetraenoyl]oxy-3-phosphonooxypropyl] (5E,8E,11E,14E,17E,20E)-tricosa-5,8,11,14,17,20-hexaenoate
[(2S,3S,6S)-6-[3-[(E)-dodec-5-enoyl]oxy-2-[(5E,7E,9E,11E,13E)-hexadeca-5,7,9,11,13-pentaenoyl]oxypropoxy]-3,4,5-trihydroxyoxan-2-yl]methanesulfonic acid
[(2S,3S,6S)-6-[3-[(3E,6E,9E)-dodeca-3,6,9-trienoyl]oxy-2-[(9E,11E,13E)-hexadeca-9,11,13-trienoyl]oxypropoxy]-3,4,5-trihydroxyoxan-2-yl]methanesulfonic acid
7,7'-bis[2-(4-hydroxyphenyl)ethyl]-2,2,2',2'-tetramethyl-8,8'-bis(3-methylbut-2-en-1-yl)-[4,6'-bichromene]-5,5'-diol
(11s)-11-{[(2r,3r,4s,5r,6r)-3-{[(2s,3r,4s,5s,6r)-4,5-dihydroxy-6-(hydroxymethyl)-3-{[(2s,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}oxan-2-yl]oxy}-4,5-dihydroxy-6-methyloxan-2-yl]oxy}hexadecanoic acid
(2s)-2-[(1s,2s,3as,3br,7s,9ar,9bs,11as)-1-hydroxy-9a,11a-dimethyl-7-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-2-{[(2s,3r,4s,5s)-3,4,5-trihydroxyoxan-2-yl]oxy}-2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl]-6-methylheptan-3-one
n-[(3s,9r,12s,13r,16s,19s,22s)-11,18-dihydroxy-16-isopropyl-19-[(4-methoxyphenyl)methyl]-13,20-dimethyl-2,8,15,21-tetraoxo-9-propyl-14-oxa-1,7,10,17,20-pentaazatricyclo[20.3.0.0³,⁷]pentacosa-10,17-dien-12-yl]ethanimidic acid
(2s,3r,4s,5r)-2-{[(2r,3r,4s,5r,6r)-3,5-dihydroxy-2-methyl-6-[(1'r,2s,2's,3s,4's,5s,7's,8'r,9's,12's,13'r,16's,18's,19's)-5,7',9',13'-tetramethyl-5'-oxaspiro[oxane-2,6'-pentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosane]-3,16'-dioloxy]oxan-4-yl]oxy}oxane-3,4,5-triol
(9s)-5-(2-{[(1s)-6,7-dimethoxy-2-methyl-3,4-dihydro-1h-isoquinolin-1-yl]methyl}-4,5-dimethoxyphenoxy)-4,14,15,16-tetramethoxy-10-methyl-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(16),2(7),3,5,13(17),14-hexaene
(1r,2s,3as,3bs,9ar,9bs,11as)-2-{[(2s,3r,4s,5r)-3,5-dihydroxy-4-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]oxy}-1-[(2s,3s,6s)-3,7-dihydroxy-6-methylheptan-2-yl]-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,5h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-one
(4r,8r,9r,10r)-5-(acetyloxy)-10-[(3r,5s)-5-(acetyloxy)-3-(furan-3-yl)-2-methylcyclopent-1-en-1-yl]-9-[(acetyloxy)methyl]-4,8,10-trimethyl-11-[(2-methylpropanoyl)oxy]-2-oxatricyclo[6.3.1.0⁴,¹²]dodecan-7-yl (2e)-2-methylbut-2-enoate
(11s)-11-{[(2r,3r,4s,5r,6r)-3-{[(2s,3r,4s,5r,6r)-4,5-dihydroxy-6-(hydroxymethyl)-3-{[(2s,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}oxan-2-yl]oxy}-4,5-dihydroxy-6-methyloxan-2-yl]oxy}hexadecanoic acid
(3e,5s,6s,7s,9r,13e,15r,16r)-15-({[(2r,3r,4r,5r,6r)-5-hydroxy-3,4-dimethoxy-6-methyloxan-2-yl]oxy}methyl)-6-{[(4s,5r,6r,7s,9r)-6-hydroxy-4,9-dimethyl-2-oxo-1,3,8-trioxaspiro[4.5]decan-7-yl]oxy}-5,7,9,16-tetramethyl-1-oxacyclohexadeca-3,13-diene-2,10-dione
11-hydroxyhexadecanoic acid; (s)-form,o-[alpha-l-rhamnopyranosyl-(1→2)-beta-d-glucopyranosyl-(1→2)-beta-d-fucopyranoside]
{"Ingredient_id": "HBIN000445","Ingredient_name": "11-hydroxyhexadecanoic acid; (s)-form,o-[alpha-l-rhamnopyranosyl-(1\u21922)-beta-d-glucopyranosyl-(1\u21922)-beta-d-fucopyranoside]","Alias": "NA","Ingredient_formula": "C34H62O16","Ingredient_Smile": "NA","Ingredient_weight": "0","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "NA","TCMSP_id": "NA","TCM_ID_id": "9386","PubChem_id": "NA","DrugBank_id": "NA"}
16β-[(α-l-arabinopyranosyl)oxy]-3β-[(β-d-glu-copyranosyl)oxy]-17α-hydroxycholest-5-en-22-one
{"Ingredient_id": "HBIN001823","Ingredient_name": "16\u03b2-[(\u03b1-l-arabinopyranosyl)oxy]-3\u03b2-[(\u03b2-d-glu-copyranosyl)oxy]-17\u03b1-hydroxycholest-5-en-22-one","Alias": "NA","Ingredient_formula": "C38H62O13","Ingredient_Smile": "CC(C)CCC(=O)C(C)C1(C(CC2C1(CCC3C2CC=C4C3(CCC(C4)OC5C(C(C(C(O5)CO)O)O)O)C)C)OC6C(C(C(CO6)O)O)O)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "1578","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
25(S)-5β-1β,3β-diol 1-O-β-D-xylopyranosyl-(1→2)-α-L-rhamnopyranoside
{"Ingredient_id": "HBIN004782","Ingredient_name": "25(S)-5\u03b2-1\u03b2,3\u03b2-diol 1-O-\u03b2-D-xylopyranosyl-(1\u21922)-\u03b1-L-rhamnopyranoside","Alias": "NA","Ingredient_formula": "C38H62O13","Ingredient_Smile": "CC1CCC2(C(C3(C(O2)CC4C3(CCC5C4CCC6C5(C(CC(C6)O)OC7C(C(C(CO7)O)O)OC8C(C(C(C(O8)C)O)O)O)C)C)O)C)OC1","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "41978","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}